NCT00895466View on ClinicalTrials.gov

Efficacy and Safety Study of the Therapeutic Vaccine PEP223 in Prostate Cancer Patients

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

December 31, 2009

Conditions
Prostate Cancer
Interventions
BIOLOGICAL

PEP-223/CoVaccine HT

Trial Locations (2)

9713 GZ

RECRUITING

UMC Groningen, Groningen

Unknown

RECRUITING

UMC Nijmegen, Nijmegen

Sponsors
All Listed Sponsors
collaborator

TFS Trial Form Support

INDUSTRY

lead

Pepscan Therapeutics

INDUSTRY